Age-Related

Becoming more forgetful and feeling slower in your thinking is normal in older age. But when these changes are more than you’d expect for your age it might be a sign of mild cognitive impairment. So does that mean you’ll soon develop dementia?

Avoidant restrictive food intake disorder is often misunderstood as extreme picky eating. But for millions of children, it’s a serious condition with real consequences for growth, nutrition and daily life. A new study shows how ARFID can be treated.

A novel three-in-one medication has been put to the test in a trial of 212 heart failure patients, in an effort to find an easier and more effective way to treat the condition. The findings were just what the scientists had hoped to see.

Strength training has long been seen as something you mainly do to build muscle or look good. But a new study adds to a growing body of evidence that shows lifting weights does far more than change how we look. It may help us live longer.

A new study has found that the stride length of a dog’s front legs can be used to accurately diagnose their cognitive decline. Because a person’s change in gait can play a significant role in spotting early signs of Alzheimer's disease or dementia.

A landmark study is due to start in the coming months, and if successful it could ultimately revive our immune system in older age and even treat chronic illnesses like autoimmune disease. The Phase 1 trial is aiming to rejuvenate senescent T cells.

In a massive study of 82,826 adults, bright artificial light in the evenings has been tied to age-related eye disease. At the extreme, light exposure was linked to a worrying increase in age-related macular degeneration, cataracts and glaucoma.

People taking fish-oil supplements in an effort to shield their brain from Alzheimer's disease might be better off investing that money in their diet, with a two-year study finding that omega-3 pills offer no protection from cognitive decline.

Scientists have not just found a new way that aging cells drive inflammation, but have also blocked it from happening with an existing FDA-approved drug. This opens the door to an entirely new way to shield the body from age-related health decline.

We may be on the cusp of understanding whether we can turn back time for our cells to stave off age-related disease, with the first human receiving experimental gene therapy as part of a landmark trial.

Anti-aging peptides have become one of the most talked-about experimental treatments in this emerging area of science – and one in particular, GHK-Cu, has shot to fame this year. So, what is it exactly? We separate the reality from the hype.

In the US, 6,000 women enter menopause every day, or 1.3 million in a year. Now, a study sheds light on the brain connectivity changes that happen in this phase, paving the way to finally understanding and ideally treating midlife cognitive decline.